Analyst Ratings for Pacira Pharmaceuticals (PCRX) [Neutrals]

PCRX Rating Summary

PCRX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PCRX
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $78.54 (+28.2%) * Over Last 12-Mos
Rating Score: 5 / 10   Percentile Rank: 50%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/11/2021 Northland Capital Markets Tim Chiang Downgrade Market Perform
(Outperform)
75.00
(N/A)
77.29
(61.27)
-20.73% Details
1/21/2021 SVB Leerink Ami Fadia Downgrade Market Perform
(Outperform)
75.00
(N/A)
73.34
(61.27)
-16.46% Details
Like PCRX Ratings? Also take a look at HRTX

PCRX Ratings News